CSIMarket
 


Frequency Therapeutics Inc   (FREQ)
Other Ticker:  
 
 

FREQ's Net Cash Flow Growth by Quarter and Year

Frequency Therapeutics Inc 's Net Cash Flow results by quarter and year




FREQ Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 8.11 -32.43 -3.89
III Quarter September 2.02 1.47 -23.09 28.86
II Quarter June -0.88 -7.46 -34.20 -7.71
I Quarter March -11.10 -29.81 -51.11 4.63
FY   -9.96 -27.69 -140.83 21.89



FREQ Net Cash Flow third quarter 2023 Y/Y Growth Comment
Frequency Therapeutics Inc achieved in the third quarter 2023, above Company average Net Cash Flow growth of 37.28% year on year, to $ 2.02 millions.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Net Cash Flow growth. While Frequency Therapeutics Inc ' s Net Cash Flow rise of 37.28% ranks overall at the positon no. 293 in the third quarter 2023.




FREQ Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September 37.28 % - - -71.17 %
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -86.14 %

Financial Statements
Frequency Therapeutics Inc 's third quarter 2023 Net Cash Flow $ 2.02 millions FREQ's Income Statement
Frequency Therapeutics Inc 's third quarter 2022 Net Cash Flow $ 1.47 millions Quarterly FREQ's Income Statement
New: More FREQ's historic Net Cash Flow Growth >>


FREQ Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 451.7 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -92 %
FY (Year on Year)   - - - -86.14 %




Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #43
Overall #293

Net Cash Flow Y/Y Growth Statistics
High Average Low
37 % -17.08 % -71.17 %
(Sep 30 2023)   (Sep 30 2020)
Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #43
Overall #293
Net Cash Flow Y/Y Growth Statistics
High Average Low
37 % -17.08 % -71.17 %
(Sep 30 2023)   (Sep 30 2020)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Frequency Therapeutics Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FREQ's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2023Seasonal Frequency Therapeutics Inc in the circumstances net cash outflow of $ 2.02 millionsSeasonal circumstances seem to have led to Frequency Therapeutics Inc 's return to recovery, as FREQ deliverNet Cash Flow of $ 2.02 millions in the III. Quarter 2023 emerging from net cash outflow-0.88 millions in the second quarter. Frequency Therapeutics Inc announced in the III. Quarter 2023 Net Cash Flow of $ 2.02 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Frequency Therapeutics Inc achieved highest sequential Net Cash Flow growth. While Frequency Therapeutics Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FREQ's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2023Periodic Frequency Therapeutics Inc in the factors net cash outflow of $ 2.02 millionsPeriodic factors have added to Frequency Therapeutics Inc 's return to profitability, as FREQ clinchesNet Cash Flow of $ 2.02 millions in the III. Quarter 2023 emerging from net cash outflow-0.88 millions in the second quarter. Frequency Therapeutics Inc announced in the III. Quarter 2023 Net Cash Flow of $ 2.02 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Frequency Therapeutics Inc achieved highest sequential Net Cash Flow growth. While Frequency Therapeutics Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Frequency Therapeutics Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -1.86 $ -2.40 $ -8.98 $ -27.68 $ -68.22
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Frequency Therapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Frequency Therapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
FREQ's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for FREQ's Competitors
Net Cash Flow Growth for Frequency Therapeutics Inc 's Suppliers
Net Cash Flow Growth for FREQ's Customers

You may also want to know
FREQ's Annual Growth Rates FREQ's Profitability Ratios FREQ's Asset Turnover Ratio FREQ's Dividend Growth
FREQ's Roe FREQ's Valuation Ratios FREQ's Financial Strength Ratios FREQ's Dividend Payout Ratio
FREQ's Roa FREQ's Inventory Turnover Ratio FREQ's Growth Rates FREQ's Dividend Comparisons



Companies with similar Net Cash Flow rise for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2023
Tracon Pharmaceuticals Inc 64.12%$ 64.124 millions
Achari Ventures Holdings Corp I62.13%$ 62.129 millions
Acumen Pharmaceuticals Inc 60.96%$ 60.955 millions
Seastar Medical Holding Corporation58.66%$ 58.659 millions
Integrated Biopharma Inc52.69%$ 52.688 millions
Brainstorm Cell Therapeutics inc 49.81%$ 49.805 millions
Akili Inc 39.83%$ 39.834 millions
Monte Rosa Therapeutics Inc 38.64%$ 38.642 millions
Frequency Therapeutics Inc 37.00%$ 36.999 millions
Abbvie inc 36.76%$ 36.756 millions
Neptune Wellness Solutions Inc 35.13%$ 35.132 millions
3m Company29.33%$ 29.326 millions
Amicus Therapeutics inc 24.64%$ 24.638 millions
Stryker Corp22.07%$ 22.074 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com